- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapse Multiple Myeloma in Italy
Total 1083 results
-
PfizerRecruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaItaly
-
Oncopeptides ABTerminatedRelapsed and/or Relapsed-refractory Multiple MyelomaUnited States, Netherlands, Denmark, Sweden, Italy
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | NPM1 MutationItaly
-
Ciceri FabioAssociazione Italiana per la Ricerca sul Cancro; Gruppo Italiano Trapianto...Recruiting
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
EMN Research ItalyActive, not recruitingRelapsed Multiple MyelomaItaly
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States, Italy
-
Molecular Partners AGCompletedMultiple Myeloma in RelapsePoland, Italy, Germany, Denmark, Czechia, Austria
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Mario BoccadoroActive, not recruiting
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, United Kingdom, Germany, Sweden
-
Azienda Ospedaliera Universitaria SeneseJanssen-Cilag S.p.A.RecruitingMyeloma MultipleItaly
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
Fondazione EMN Italy OnlusTerminated
-
Janssen Pharmaceutica N.V., BelgiumRecruitingRelapsed/Refractory Multiple MyelomaGermany, Italy, Belgium, Spain, Netherlands, France, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Belgium, Italy, Korea, Republic of, Hong Kong, Israel, Finland, Spain, Japan, United States
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
AGC Biologics S.p.A.Horizon 2020 - European CommissionTerminatedAcute Myeloid Leukemia | Multiple MyelomaItaly, Czechia
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Netherlands, Italy
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Japan, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Netherlands, Poland, Austria, Portugal, Greece, India
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Italy, Korea, Republic of, Taiwan, China, Germany, Turkey, Japan, France, United Kingdom, Brazil, Spain, Czechia, Poland, Israel, Belgium, Greece, Netherlands
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
Tiziana MarangonWithdrawn
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States, Italy
-
Menarini GroupTerminatedRecurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseFrance, Germany, Italy, Spain, Belgium
-
Gruppo Italiano Studio LinfomiUnknown
-
Azienda Ospedaliera San Giovanni BattistaUnknown
-
Azienda Ospedaliera Universitaria Mater Domini,...Associazione Italiana per la Ricerca sul CancroCompletedAdvanced Solid Tumor | Hepatocarcinoma | Multiple Myeloma, RefractoryItaly
-
Fondazione EMN Italy OnlusTerminated
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Non-Hodgkin Lymphoma | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell MyelomaUnited States, Germany, Italy
-
IRCCS Policlinico S. MatteoRecruitingAL Amyloidosis | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaItaly
-
Fondazione EMN Italy OnlusCompleted
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingSmouldering MyelomaNetherlands, Norway, Czechia, Italy
-
University Of PerugiaRecruitingLymphoma | Acute Myeloid Leukemia | Myeloproliferative Disorders | Multiple Myeloma | Acute Lymphoid Leukemia | Other Hematologic Malignant NeoplasmsItaly
-
Bristol-Myers SquibbAbbottTerminatedNewly Diagnosed, Previously Untreated Multiple MyelomaUnited States, Poland, Italy, Greece
-
Arog Pharmaceuticals, Inc.RecruitingRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States, Germany, Spain, Italy, France, Canada
-
SanofiCompleted
-
National Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Italy
-
Gruppo Italiano per lo Studio del Mieloma MultiploCompleted
-
Azienda Ospedaliera Cardinale G. PanicoCompletedPelvic Organ Prolapse | Posterior Vaginal Wall ProlapseItaly